|
FY2026
12 months to Jan 31, 2026
|
FY2025
12 months to Jan 31, 2025
|
FY2024
12 months to Jan 31, 2024
|
FY2023
12 months to Jan 31, 2023
|
FY2022
12 months to Jan 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Non-cash operating lease costs | |||||
| Amortization of deferred commissions | |||||
| Asset impairment related to office facility exit | |||||
| Stock-based compensation, net of amounts capitalized | |||||
| Net accretion of discounts on investments | |||||
| Net unrealized losses (gains) on strategic investments in equity securities | |||||
| Net realized and unrealized losses (gains) on strategic investments in equity securities | |||||
| Amortization of debt issuance costs | |||||
| Deferred income tax | |||||
| Non-cash restructuring charges (recoveries), net | |||||
| Other | |||||
| Changes in operating assets and liabilities, net of effects of business combinations: | |||||
| Accounts receivable | |||||
| Deferred commissions | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Deferred revenue | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Purchases of property and equipment | |||||
| Capitalized software development costs | |||||
| Cash paid for business combinations, net of cash, cash equivalents, and restricted cash acquired | |||||
| Purchases of intangible assets | |||||
| Purchases of investments | |||||
| Sales of investments | |||||
| Maturities and redemptions of investments | |||||
| Settlement of cash flow hedges | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under employee stock purchase plan | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchases of common stock | |||||
| Distributions to noncontrolling interest holders | |||||
| Payments of deferred purchase consideration for business combinations | |||||
| Gross proceeds from issuance of convertible senior notes | |||||
| Cash paid for issuance costs on convertible senior notes | |||||
| Purchases of capped calls related to convertible senior notes | |||||
| Capital contributions from noncontrolling interest holders | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash—beginning of period | |||||
| Cash, cash equivalents, and restricted cash—end of period | |||||
| Cash paid for income taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities | |||||
| Property and equipment included in accounts payable and accrued expenses | |||||
| Stock-based compensation included in capitalized software development costs | |||||
| Issuance of common stock in connection with business combinations | |||||
| Unpaid taxes related to net share settlement of equity awards included in accrued expenses and other current liabilities | |||||
| Reconciliation of cash, cash equivalents, and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash—included in other assets and prepaid expenses and other current assets | |||||
Loading...